CliffBio
small molecule

SUPRENZA

PHENTERMINE HYDROCHLORIDE

Loss of exclusivityMarch 2029latest FDA-listed patent expiry
CompanyCitius Pharmaceuticals →View the full company profile on CliffBio

Drug detail

Brand nameSUPRENZA
Active ingredientPHENTERMINE HYDROCHLORIDE
Strength30MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
Dosage formTABLET, ORALLY DISINTEGRATING
RouteORAL
ModalitySmall molecule
FDA approvalJune 2011
Marketing statusDISCN

Listed patents

PatentExpiresType
8440170March 2029product

More from Citius Pharmaceuticals

Source: FDA Orange Book, layered on the CliffBio company graph. Cliff dates are the latest FDA-listed patent expiry; estimates are projections, not legal advice.

SUPRENZA patent cliff — loss of exclusivity March 2029 | CliffBio